Skip to main content
. 2016 Mar 31;3(3):177–188. doi: 10.1002/ehf2.12088

Figure 4.

Figure 4

Tolvaptan preserved systemic BP during intensive treatment. Changes of systolic BP (A) and diastolic BP (B) from baseline to intensive treatment end. *P < 0.05 vs. furosemide. #P < 0.05 vs. baseline in the furosemide group. §P < 0.05 vs. admission. TLV indicates tolvaptan.